SOPHiA GENETICS SA (SOPH) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$6.83

From 52W high−27.24%

Volume510904.00

Market cap$552.48M

P/E (TTM)—

P/S (TTM)6.4x

Div yield—

Key dataOct 19, 2026

Open

$6.83

From 52W high

−27.24%

Volume

510904.00

Market cap

$552.48M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.9x

P/E (TTM)

—

RSI (14)

33.3

MomentumView details →

1D Return

−3.57%

YTD Return

+41.76%

SummaryUpdated Jun 1, 2026

SOPHiA GENETICS SA (NASDAQ:SOPH) is a Swiss healthcare technology company founded in 2011 and headquartered in Saint-Sulpice, Switzerland. The company went public in July 2021, positioning itself as a leader in data-driven medicine through artificial intelligence and cloud computing. SOPHiA GENETICS has built a global platform that serves hospitals, laboratories, and biopharmaceutical companies across more than 70 countries, with nearly 800 healthcare institutions using its technology to analyze genomic data for precision medicine applications.

Ask drillr about SOPHiA GENETICS SA →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−7.9x

EV/Sales

5.9x

P/S (TTM)

6.4x

P/B (TTM)

6.6x

ProfitabilityView details →

Gross Margin

66.63%

Net Margin

−93.86%

EBITDA Margin

−74.02%

ROE (TTM)

−97.31%

ROA (TTM)

−40.77%

Asset Turnover

0.48x

GrowthView details →

Revenue YoY

+23.65%

EPS YoY

−4.55%

FCF YoY

−2.65%

Revenue CAGR 3Y

+17.56%

EPS CAGR 3Y

−23.16%

EBITDA YoY

−18.67%

MomentumView details →

1D Return

−3.57%

YTD Return

+41.76%

1Y Return

+58.00%

RSI (14)

33.3

vs 50D SMA

−16.50%

vs 200D SMA

+13.38%

Capital & dividendView details →

Debt/Equity

0.74x

Current Ratio

2.69x

Quick Ratio

2.55x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.26

EPS Surprise

−23.79%

Beats (12Q)

4/12

Next Q EPS Est

−$0.17

Avg Surprise (4Q)

−26.65%

Rev Surprise

7.32%

Financials snapshotView financials →

Revenue (TTM)

86.17M

Net Income (TTM)

−80.88M

Op. CF (TTM)

−41.60M

Next earningsNov 3, 2026 →

Latest newsMore news →

SOPHiA GENETICS (SOPH) shares rose 7.0% in the previous trading session on higher-than-average volume.31d ago

SOPHiA GENETICS reported financial results for the second quarter ended June 30, 2026, with revenue of $23.3 million, up 27% year-over-year, and a net loss of $22.4 million.76d ago

Similar companies

HealthyWay Inc.02587.HK Evolent Health, Inc.EVH MedSci Healthcare Holdings Limited02415.HK National Research CorporationNRC QingSong Health Corp02661.HK Phreesia, Inc.PHR Find similar companies →

Latest newsMore news →

SOPHiA GENETICS (SOPH) shares rose 7.0% in the previous trading session on higher-than-average volume.31d ago SOPHiA GENETICS reported financial results for the second quarter ended June 30, 2026, with revenue of $23.3 million, up 27% year-over-year, and a net loss of $22.4 million.76d ago